[1] Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis[J]. J Nucl Med, 2012, 53(10):1543-1549. DOI:10.2967/jnumed.112.104380.
[2] Al-Kofahi K, Korsten P, Ascoli C, et al. Management of extrapulmonary sarcoidosis:challenges and solutions[J]. Ther Clin Risk Manag, 2016, 12:1623-1634. DOI:10.2147/TCRM.S74476.
[3] 张悦, 高硕, 李祖贵, 等.结节病18F-FDG PET/CT显像误诊为淋巴瘤一例[J].中华核医学杂志, 2006, 26(6):375. DOI:10.3760/cma.j.issn.2095-2848.2006.06.023.
Zhang Y, Gao S, Li ZG, et al. Misdiagnosis of sarcoidosis with lymphoma using 18F-FDG PET/CT[J]. Chin J Nucl Med, 2006, 26(6):375.  doi: 10.3760/cma.j.issn.2095-2848.2006.06.023
[4] Mostard RL, Prompers L, Weijers RE, et al. 18F-FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients[J]. Clin Nucl Med, 2012, 37(1):21-25. DOI:10.1097/RLU.0b013e3182335f9b.
[5] Keijsers RG, Verzijlbergen FJ, Oyen WJ, et al. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis[J]. Eur J Nucl Med Mol Imaging, 2009, 36(7):1131-1137. DOI:10.1007/s00259-009-1097-x.